Accelerated atherosclerosis in a cardiac transplant patient  by Nitkin, Robert S. et al.
lACC Vol. 6. No. I 
July 1985:243-·5 
CASE REPORTS 
243 
Accelerated Atherosclerosis in a Cardiac Transplant Patient 
ROBERT S. NITKIN, MD, FRCP(C), SHARON A. HUNT, MD, FACC, 
JOHN S. SCHROEDER, MD, FACC 
Stanford, California 
A cardiac transplant patient with rapidly progressive 
graft atherosclerosis is described. This case demon-
strates the accelerated nature of this disease and prob-
lems in diagnosis, as well as an unexpected and previ-
ously unreported lack of sensitivity of exercise thallium 
-------------------------
The renewed interest in cardiac transplantation and im-
proved patient survival rates since the introduction of cy-
closporin have resulted in an increasing number of long-
term survivors of this procedure. Experience with more than 
300 heart and heart-lung transplantations performed at our 
institution has shown that one of the more serious long-term 
problems encountered is accelerated coronary atheroscle-
rosis in the cardiac allograft. This process is detectable by 
coronary arteriography in approximately 40% of our patients 
at 5 years after transplantation. We report a case that is 
representative of this problem and illustrates how difficult 
its diagnosis may be owing to the lack of symptoms of 
myocardial ischemia. 
Case Report 
Clinical history and findings. A previously healthy 24 
year old male student presented in October 1981, complain-
ing of a 5 day history of chest pressure accompanied by 
shortness of breath. Physical examination revealed mild res-
piratory distress, a supine blood pressure of 100/80 mm Hg 
and a pulse of llO/min. Jugular venous distension. cardio-
megaly, a loud third heart sound, a grade 2/6 pansystolic 
murmur radiating to the axilla and crackles in both lung 
bases were noted. 
Routine blood chemistry determinations, serum choles-
terol and viral titers were normal. Electrocardiography re-
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scintigraphy in its investigation. This case also gives fur-
ther support to the practice of routinely and frequently 
obtaining coronary arteriograms in the management of 
these patients. 
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vealed sinus rhythm, narrow QRS complexes and QS com-
plexes in leads V 2 and V 1 with inverted T waves in leads 
I, aVL and V6 . Chest X-ray study showed cardiomegaly, 
pulmonary vascular redistribution and interstitial edema. At 
cardiac catheterization, left ventriculography showed glob-
ally decreased contractility (grade IV), with mild to mod-
erate mitral insufficiency and an end-diastolic pressure of 
25 mm Hg. Results of coronary arteriography were normal. 
Diagnostic studies. At the time of biopsy, cardiac out-
put was 3.3 liters/min and cardiac index was I. 8 liters/min 
per m2 . Right heart pressures were moderately elevated and 
pulmonary vascular resistance was 2.4 units. Right ven-
tricular endomyocardial biopsy revealed marked m)llOcyte 
hypertrophy and disorganization, suggestive of a cardio-
myopathy, with no evidence of myocarditis or infiltrative 
disease. Medical treatment for 3 months resulted in no im-
provement and the patient remained in New York Heart 
Association functional class IV and was accepted as a car-
diac transplant recipient. 
Operative course. On March 26, 1982, a 20 year old 
type 0 positive donor heart with human leukocyte antigen 
(HLA) typing A3-B7-BW6 became available. Routine or-
thotopic transplant procedure on the 0 positive recipient 
whose HLA type was A2-AII-BW4-BW6-BW35-BW57 was 
uneventful. Careful inspection of the donor heart at the time 
of transplantation revealed no abnormalities and no evidence 
of coronary artery disease. The heart removed from the 
patient weighed 550 g and all four chambers were hyper-
trophied. No coronary artery disease was detectable, and 
microscopic examination showed features consistent with 
cardiomyopathy. 
Postoperative course. The patient was started on an 
immunosuppressive regimen consisting of cyclosporin and 
prednisone. The initial postoperative period was compli-
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cated by several rejection episodes treated successfully with 
high dose steroids, a cytomegalovirus infection and a herpes 
zoster infection. By 8 weeks after transplantation, he was 
clinically well and returned to his studies. 
On his first annual post-transplantation admission in March 
1983, he was normotensive and his only medications in-
cluded cyclosporin, prednisone (8 mg twice daily) and di-
pyridamole (Persantine). Cardiac catheterization revealed 
normal hemodynamic status, a normal ventriculogram and 
entirely normal coronary arteries. Fasting blood glucose of 
Figure 1. Left coronary artery angiograms in the right anterior 
oblique (A) and left anterior oblique (B) views obtained at the 
time of the second annual cardiac catheterization after transplantation. 
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98 mg/100 ml and all serum lipids were normal. Except 
for one further episode of mild rejection noted on routine 
surveillance right ventricular biopsy and treated with 100 
mg daily of oral prednisone for 3 days with subsequent rapid 
tapering in September 1983, the patient remained free of 
complications and was able to continue all of the normal 
activities of daily living. 
Figure 2. Left coronary artery angiograms in the right anterior 
oblique (A) and left anterior oblique (B) views obtained only 12 
weeks after the study seen in Figure 1. Note the marked progression 
in the severity of the lesions. 
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Long-term follow-up. At his second annual admission 
in April 1984, cardiac catheterization again revealed normal 
hemodynamics; results of left ventriculography were normal 
except for trace mitral insufficiency. Coronary arteriog-
raphy, however, revealed discrete 40 to 50% narrowing of 
luminal diameter in the first and second obtuse marginal 
branches of the circumflex artery (Fig. I), as well as a 50 
to 60% stenotic lesion at the terminal bifurcation of the right 
coronary artery. Diffuse disease of lesser severity was also 
noted in all three major coronary vessels. 
On a routine exercise thallium study, maximal blood 
pressure, pulse and work load of 136/80 mm Hg, 140/min 
and 6 METS, respectively, were obtained and the test was 
terminated because of fatigue. The electrocardiogram and 
the immediate post-exercise and 4 hour delayed thallium 
images showed no evidence of ischemia. Biopsy revealed 
moderate acute rejection with myocyte necrosis, which was 
again treated with steroid therapy resulting in subsequent 
resolution. In view of the coronary artery disease. it was 
decided to obtain a repeat angiogram in 3 months. 
On readmission 12 weeks later, the patient complained 
only of mild dyspnea on exertion. Fasting blood glucose 
and lipid studies remained normal. He was normotensive 
and new findings included a fourth heart sound, mild ankle 
edema and mild cardiomegaly with pulmonary vascular re-
distribution on X -ray study. The electrocardiogram re-
mained unchanged. Diuretic drug treatment was instituted. 
Cardiac catheterization on that admission revealed con-
tinued normal hemodynamics. Left coronary angiography 
showed discrete 80 to 95% stenotic lesions in the mid and 
distal left anterior descending coronary artery and first, sec-
ond and third diagonal branches, with a totally occluded 
distal circumflex vessel. The first and second obtuse mar-
ginal branches contained localized 80 and 90% lesions, re-
spectively (Fig. 2). The right coronary artery had a 95% 
discrete narrowing proximally. Right ventricular biopsy at 
that time again showed evidence of acute rejection for which 
the patient is currently being treated. 
Because of the severity and rapidity of progression of 
his coronary artery disease, the patient was offered the op-
tion of elective retransplantation and is currently awaiting 
the availability of a suitable donor. 
Discussion 
Historical observations. By the early 1970s (I), it be-
came apparent that one of the major impediments to long-
term survival in transplant patients was graft atherosclerosis. 
Possible causative factors that have been examined include 
age of the transplanted organ, histocompatibility of the match, 
type of immunosuppression used and clinical variables of 
the recipient such as underlying heart disease, number and 
degree of rejection episodes and the usual known risk factors 
of obesity, lipid status, glucose intolerance, family history, 
hypertension and smoking history. There has been no def-
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inite correlation with any of these factors except donor age. 
More recently, a retrospective study from our institution (2) 
suggested that patients with underlying coronary artery dis-
ease as the cause of their initial transplantation are more 
likely to develop accelerated coronary artery disease than 
are those with normal vessels at the outset. However, this 
is not true in this isolated case. 
Diagnostic and therapeutic difficulties. That the rap-
idity of this disease process is quite different from the coro-
nary artery disease seen in patients without a cardiac trans-
plant gives further support to the view that an immunologic 
mechanism is involved in this atherosclerotic process (3). 
Using a rat heterotopic heart transplant model, Lurie et al. 
(4) demonstrated that dipyridamole decreased immunolog-
ically induced arterial injury in this model; unfortunately, 
this has not proven to be as effective in human patients. 
The disease appears to develop despite this agent and be-
cause of cardiac denervation, all too often presents as silent 
myocardial infarction, sudden death or congestive heart fail-
ure (5). 
Our patient's negative exercise thallium study is difficult 
to explain. Previous work (6) outlined some of the diffi-
culties in interpreting thallium-201 images in patients who 
have undergone cardiac transplantation. Frequent false pos-
itive studies are anticipated, possibly related to myocardial 
ischemia induced by immunologically mediated small vessel 
disease. The reason for the false negative study in our case 
is unclear. 
Implications. Until further work in this area gives some 
clues to the cause of accelerated atherosclerosis in cardiac 
allograft recipients and possible modes of halting it, we will 
continue to offer patients the option of repeat orthotopic 
cardiac transplantation, which does offer an acceptable al-
ternative to patients with allograft failure (7). 
We thank Stephen Oesterle. MD for his assistance in the catheterization 
laboratory. as well as Lynne Blagg for her help with the preparation of 
the manuscript. 
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